Pfizer Inc (PFE)
40.39
+0.21 (+0.52%)
USD |
NYSE |
Mar 24, 16:00
40.61
+0.22 (+0.54%)
Pre-Market: 06:45
Pfizer Income from Discontinued Operations (Quarterly)
Income from Discontinued Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Income from Discontinued Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | -- |
| September 30, 2022 | -- |
| June 30, 2022 | -- |
| March 31, 2022 | -- |
| December 31, 2021 | -- |
| September 30, 2021 | -- |
| June 30, 2021 | -- |
| March 31, 2021 | -- |
| December 31, 2020 | -- |
| September 30, 2020 | -- |
| June 30, 2020 | -- |
| March 31, 2020 | -- |
| December 31, 2019 | -- |
| September 30, 2019 | -- |
| June 30, 2019 | -- |
| March 31, 2019 | -- |
| December 31, 2018 | -- |
| September 30, 2018 | -- |
| June 30, 2018 | -- |
| March 31, 2018 | -- |
| December 31, 2017 | -- |
| September 30, 2017 | -- |
| June 30, 2017 | -- |
| March 31, 2017 | -- |
| December 31, 2016 | -- |
| Date | Value |
|---|---|
| September 30, 2016 | -- |
| June 30, 2016 | -- |
| March 31, 2016 | -- |
| December 31, 2015 | -- |
| September 30, 2015 | -- |
| June 30, 2015 | -- |
| March 31, 2015 | -- |
| December 31, 2014 | -- |
| September 30, 2014 | -- |
| June 30, 2014 | -- |
| March 31, 2014 | -- |
| December 31, 2013 | -- |
| September 30, 2013 | -- |
| June 30, 2013 | -- |
| March 31, 2013 | -- |
| December 31, 2012 | -- |
| September 30, 2012 | -- |
| June 30, 2012 | -- |
| March 31, 2012 | -- |
| December 31, 2011 | -- |
| September 30, 2011 | -- |
| June 30, 2011 | -- |
| March 31, 2011 | -- |
| December 31, 2010 | -- |
| September 30, 2010 | -- |
Income from Discontinued Operations Definition
Income from operations that used to be a part of the business but are not any longer. This could be due to the sale of a portion of a business, shutting down a division, or something else.
Income from Discontinued Operations (Quarterly) Range, Past 5 Years
Income from Discontinued Operations (Quarterly) Benchmarks
| Moderna Inc | -- |
| Amgen Inc | -- |
| Gilead Sciences Inc | -- |
| Johnson & Johnson | -- |
| Eli Lilly and Co | -- |